Archive for April, 2011

CBRX submits PROCHIEVE NDA, SGMO data release update

Apr 29, 2011 No Comments by

Sangamo BioSciences, Inc. (Nasdaq: SGMO) today said they expect top-line efficacy data of their Phase 2b Clinical Trial in Diabetic Neuropathy in 2H 2011. Previous guidance released in February was for data during 4Q 2011. Columbia Laboratories, Inc. (Nasdaq: CBRX), and Watson Pharmaceuticals, Inc. (NYSE: WPI), today announced that they had submitted their NDA for […]

Daily News Read more

CRIS final BCC pivotal data due Jun 20-23 + news from ISTA AFFY ADLR CYTR ANX

Apr 28, 2011 No Comments by

Curis, Inc. (NASDAQ: CRIS) said today that full data from the pivotal Phase II clinical trial of the Hedgehog pathway inhibitor vismodegib (formerly designated GDC-0449), will be presented at the 7th Annual Congress of the European Association of Dermato-Oncology, in Nantes, France, June 20-23, 2011 with an anticipated NDA filing by Roche later this year. […]

Daily News Read more

CAPS to delist to OTC. NEOP files shelf. SPPI maintains guidance

Apr 27, 2011 No Comments by

Capstone Therapeutics Corp. (Nasdaq: CAPS) said today that following feedback from shareholders a reverse split will not be initiated. Rather they will face a delisting to OTC as a result of failing to push their bid price above $1.00 for 10 consecutive days prior to the May 2, 2011 deadline set by NASDAQ. Neoprobe Corporation […]

Daily News Read more

XNPT granted SPA. APPA delist. IDRA delay + KERX

Apr 25, 2011 No Comments

dera Pharmaceuticals, Inc. (Nasdaq: IDRA) announced on Friday, of all days, that it will delay initiating its planned Phase 2 clinical trial of IMO-2125 plus ribavirin in treatment-naive, genotype 1 hepatitis C virus (HCV) patients, based on preliminary data from a 26-week nonclinical toxicology study of IMO-2125 in rodents. Preliminary analysis of the histology data […]

Read more

ASCO 2011 Calendar

Apr 24, 2011 No Comments

For those of you new to the site I have put together an ASCO 2011 Calendar of companies presenting that are followed by BioPharmCatalyst. There are some companies that I have heard chatter of that will be presenting but have not been able to find them listed on the ASCO website. These companies are AEZS […]

Read more

April 22, 2011

Apr 22, 2011 No Comments

Some short and long term potential catalysts (share prices as at the close of trading Friday, April 15, 2011). See the links in the FDA Calendar for more details about each catalyst. The possible catalysts listed below represent both short and long opportunities. It is NOT a recommendation to take SHORT or LONG positions in […]

Read more